Brandon Medical’s i2i Quasar eLite operating theatre light was recently shortlisted in the Excellence in Product Design (Medical) category at the 2021 Elektra Awards, run by specialist industry magazine, Electronics Weekly.
Electronics Weekly said: “The judges have deliberated, debated, and discussed, and this year’s extremely high calibre of entries has yielded a phenomenally strong list of finalists.” Brandon Medical says it is thus ‘proud and excited’ to have been shortlisted. The company explains that i2i stands for ‘isolated to integrated’, with the technology developed its in-house R&D team to interconnect its products to its Intelligent Theatre Control Panel (iTCP) or a building energy management system, or to pass data from a medical device to the cloud for remote monitoring and data storage. Connectivity to mobile device applications will allow for more straightforward configuration, installation, and servicing, Brandon adds. The company explained: “Making products i2i compatible will allow Brandon Medical to integrate its products and systems with other devices in operating theatres and other clinical spaces, in turn helping healthcare facilities provide a better service to customers and partners.”
Of the i2i Quasar eLite, the company adds: “Providing automated self-testing and diagnostics as a single system, the light unit acts as a load test for the power unit to measure battery performance for instantaneous operation and performance over time, to calculate service intervals based on actual usage patterns.” The data from the i2i can be monitored via a third-party master device via an industry standard Modbus Remote Terminal Unit.
Brandon Medical’s i2i cluster of communication technologies allows data communication with its Intelligent Theatre Control Panel (iTCP) for reporting and scheduling self-test activities during empty theatre periods. The technologies enable a monitoring team to identify and highlight potential issues before the user is aware, which also allows engineers to perform a first-point fix. Theatre downtime is thus minimised, ‘saving the hospital thousands of pounds per intervention, and reducing the waiting time for patients to receive life-saving operations’. The i2i technology also accords with Brandon Medical’s ‘pledge to a Net Zero carbon footprint’.
